These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 9028369)
1. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Gilliland FD; Hunt WC; Morris DM; Key CR Cancer; 1997 Feb; 79(3):564-73. PubMed ID: 9028369 [TBL] [Abstract][Full Text] [Related]
2. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Bhattacharyya N Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769 [TBL] [Abstract][Full Text] [Related]
3. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Aschebrook-Kilfoy B; Ward MH; Sabra MM; Devesa SS Thyroid; 2011 Feb; 21(2):125-34. PubMed ID: 21186939 [TBL] [Abstract][Full Text] [Related]
5. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]. Hundahl SA; Fleming ID; Fremgen AM; Menck HR Cancer; 1998 Dec; 83(12):2638-48. PubMed ID: 9874472 [TBL] [Abstract][Full Text] [Related]
6. Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan. Lin JD; Chao TC; Sun JH; Ho C; Weng HF Oncology; 2000 May; 58(4):280-5. PubMed ID: 10838492 [TBL] [Abstract][Full Text] [Related]
7. Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival. Lin HW; Bhattacharyya N Laryngoscope; 2010 Apr; 120(4):712-6. PubMed ID: 20205241 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and therapy of differentiated thyroid gland carcinomas]. Mann K Internist (Berl); 2002 Feb; 43(2):174-85. PubMed ID: 11963755 [No Abstract] [Full Text] [Related]
9. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients. Oyer SL; Fritsch VA; Lentsch EJ Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464 [TBL] [Abstract][Full Text] [Related]
10. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population. Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534 [TBL] [Abstract][Full Text] [Related]
11. Thyroid cancer treated in Chang Gung Memorial Hospital (northern Taiwan) during the period 1979-1992: clinical presentation, pathological finding, analysis of prognostic variables, and results of treatment. Lin JD; Weng HF; Huang MJ; Huang BY; Huang HS; Jeng LB J Surg Oncol; 1994 Dec; 57(4):252-9; discussion 259-60. PubMed ID: 7990481 [TBL] [Abstract][Full Text] [Related]
12. Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014. Weeks KS; Kahl AR; Lynch CF; Charlton ME Cancer; 2018 Apr; 124(7):1483-1491. PubMed ID: 29338082 [TBL] [Abstract][Full Text] [Related]
13. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes. Balachandar S; La Quaglia M; Tuttle RM; Heller G; Ghossein RA; Sklar CA Thyroid; 2016 Feb; 26(2):219-26. PubMed ID: 26854950 [TBL] [Abstract][Full Text] [Related]
14. Unusual malignant tumors of the thyroid gland. Diaconescu MR; Costea I; Glod M; Grigorovici M; Diaconescu S Chirurgia (Bucur); 2013; 108(4):482-9. PubMed ID: 23958090 [TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905 [TBL] [Abstract][Full Text] [Related]
16. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663 [TBL] [Abstract][Full Text] [Related]
17. Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea? Oh CM; Lim J; Jung YS; Kim Y; Jung KW; Hong S; Won YJ Cancer Med; 2021 Jun; 10(12):4087-4096. PubMed ID: 33979040 [TBL] [Abstract][Full Text] [Related]
18. Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013. Milano AF J Insur Med; 2018 Jan; 47(3):143-158. PubMed ID: 30192723 [TBL] [Abstract][Full Text] [Related]
19. Tree-based model for thyroid cancer prognostication. Banerjee M; Muenz DG; Chang JT; Papaleontiou M; Haymart MR J Clin Endocrinol Metab; 2014 Oct; 99(10):3737-45. PubMed ID: 25033070 [TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment. Krook KA; Fedewa SA; Chen AY Laryngoscope; 2015 Apr; 125(4):1021-7. PubMed ID: 25583017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]